Brittany Lauther
Family · Morristown, NJNPI 1609221704
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $13,256 of the $20,287 with a category attached, or 65.3%. 34 manufacturers reported payments, led by Abbott at 46.6% of the total. Among family clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 578 payments — averaging $35.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$9K
- AOP Health US, LLC$2K
- AstraZeneca$1K
- Actelion Pharmaceuticals US, Inc.$936
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$909
- Boehringer Ingelheim$786
- plus $6K from 28 others
What the payments were for
- Travel & lodging$6103%
- Food & beverage$13,25665%
- Education$6,42132%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 82 | $9,445 |
| AOP Health US, LLC | 2 | $1,519 |
| AstraZeneca | 66 | $1,177 |
| Actelion Pharmaceuticals US, Inc. | 50 | $936 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 34 | $909 |
| Boehringer Ingelheim | 50 | $786 |
| Merck | 37 | $694 |
| Alnylam Pharmaceuticals Inc. | 38 | $624 |
| Bayer | 36 | $613 |
| United Therapeutics Corporation | 34 | $570 |
| Impulse Dynamics (USA) Inc. | 8 | $556 |
| Pfizer | 31 | $482 |
| Novartis | 32 | $468 |
| Amgen | 17 | $249 |
| Lexicon Pharmaceuticals, Inc. | 10 | $178 |
| E.r. Squibb & Sons, L.L.C. | 11 | $168 |
| Boston Scientific | 6 | $144 |
| Medtronic | 4 | $132 |
| Bridgebio Pharma, Inc. | 5 | $95 |
| Vifor Pharma, Inc. | 5 | $75 |
| Baxter Healthcare | 2 | $74 |
| Scpharmaceuticals Inc. | 4 | $73 |
| Saranas, Inc. | 1 | $68 |
| Endotronix, Inc. | 2 | $57 |
| Cvrx, Inc. | 2 | $44 |
| Daxor Corporation | 1 | $21 |
| Astellas Pharma US Inc | 1 | $19 |
| Edwards Lifesciences | 1 | $18 |
| Sanofi | 1 | $18 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Sobi, Inc | 1 | $15 |
| Kestra Medical Technology Services, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$7,201
- Rapiblyk$3,037
- CARDIOMEMS$899
- OPTIMIZER$690
- VERQUVO$227
- FARXIGA$118
- Kerendia$111
How this compares
$20,287 in reported general payments places this provider in the 95th percentile of 2,692 family providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 59 | $1,559,242 |
| EntrestoSacubitril/Valsartan | 114 | $150,876 |
| FarxigaDapagliflozin Propanediol | 50 | $60,709 |
| EliquisApixaban | 46 | $54,103 |
| JardianceEmpagliflozin | 28 | $35,713 |
| LokelmaSodium Zirconium Cyclosilicate | 29 | $23,717 |
| XareltoRivaroxaban | 11 | $16,037 |
| VascepaIcosapent Ethyl | 21 | $8,571 |
| Eplerenone | 45 | $3,002 |
| Valsartan | 38 | $2,861 |
| Torsemide | 67 | $2,064 |
| Carvedilol | 103 | $1,175 |
| Bisoprolol Fumarate | 27 | $843 |
| Spironolactone | 121 | $695 |
| Atorvastatin Calcium | 53 | $531 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerVyndamax, Eliquis | $482 | $1,613,346105 claims |
| NovartisEntresto | $468 | $150,876114 claims |
| AstraZenecaFarxiga, Lokelma | $1,177 | $84,42679 claims |
| Boehringer IngelheimJardiance | $786 | $35,71328 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,692 family providers in New Jersey.
Other family in Morristown
- Jennifer DemaioMorristown$412K
- Megan FiloramoMorristown$53K
- Jenessa DieterleMorristown$15K
- Daniil LibmanMorristown$11K
- Kara TrlicaCranbury$186K
- Nicole BauerParamus$161K
- China BattistaWall Township$142K
- Nancy EisenbergerVoorhees$82K
- Jennifer AbitabiloGlen Ridge$54K
- Shawn DenningToms River$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.